# Haploidentical Hematopoietic Stem Cell Transplantation Using A Novel Clofarabine Containing Conditioning Regimen For Patients With Refractory Hematologic Malignancies

> **NCT00824135** · PHASE1 · COMPLETED · sponsor: **St. Jude Children's Research Hospital** · enrollment: 34 (actual)

## Conditions studied

- Hematologic Malignancies

## Interventions

- **DRUG:** Clofarabine
- **PROCEDURE:** Stem Cell Transplantation, Hematopoietic
- **OTHER:** OKT3
- **DRUG:** Thiotepa
- **DRUG:** Melphalan
- **DRUG:** Mycophenolate mofetil
- **DRUG:** Rituximab
- **OTHER:** G-CSF

## Key facts

- **NCT ID:** NCT00824135
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2012-10
- **Final completion:** 2016-12
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2017-01-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00824135

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00824135, "Haploidentical Hematopoietic Stem Cell Transplantation Using A Novel Clofarabine Containing Conditioning Regimen For Patients With Refractory Hematologic Malignancies". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00824135. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*